These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1337653)

  • 1. Acute respiratory failure during pneumonia induced by Sendai virus.
    van Daal GJ; Eijking EP; So KL; Fievez RB; Sprenger MJ; van Dam DW; Erdmann W; Lachmann B
    Adv Exp Med Biol; 1992; 316():319-26. PubMed ID: 1337653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant replacement therapy in animal models of respiratory failure due to viral infection.
    van 't Veen A; So KL; Lachmann B
    Adv Exp Med Biol; 1994; 345():83-94. PubMed ID: 8079794
    [No Abstract]   [Full Text] [Related]  

  • 3. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia.
    van Daal GJ; So KL; Gommers D; Eijking EP; Fiévez RB; Sprenger MJ; van Dam DW; Lachmann B
    Anesth Analg; 1991 May; 72(5):589-95. PubMed ID: 1850209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant treatment in a pediatric burn patient with respiratory failure.
    Tortorolo L; Chiaretti A; Piastra M; Viola L; Polidori G
    Pediatr Emerg Care; 1999 Dec; 15(6):410-1. PubMed ID: 10608328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.
    Putz G; Hörmann C; Koller W; Schön G
    Intensive Care Med; 1996 Jun; 22(6):588-90. PubMed ID: 8814477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sendai virus infection of mice with protein malnutrition.
    Pena-Cruz V; Reiss CS; McIntosh K
    J Virol; 1989 Aug; 63(8):3541-4. PubMed ID: 2545924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine surfactant in full-term neonates with adult respiratory distress syndrome-like disorders.
    Gortner L; Pohlandt F; Bartmann P
    Pediatrics; 1994 Mar; 93(3):538. PubMed ID: 8115229
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant supplementation in the lung.
    Anzueto A
    Respir Care Clin N Am; 2002 Jun; 8(2):211-36. PubMed ID: 12481816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural surfactant preparation in complex therapy of acute respiratory distress syndrome in adults following open-heart surgeries].
    Bautin AE; Khubulava GG; Osovskikh VV; Rozenberg OA
    Anesteziol Reanimatol; 2003; (4):55-7. PubMed ID: 14524023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
    Lachmann B
    Eur Respir J Suppl; 1989 Mar; 3():98s-103s. PubMed ID: 2663002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cotton rat as an experimental model of human parainfluenza virus type 3 disease.
    Murphy TF; Dubovi EJ; Clyde WA
    Exp Lung Res; 1981 May; 2(2):97-109. PubMed ID: 6268401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respiratory mechanical and surfactant-dependent etiological factors in the development of acute respiratory failure].
    Benzer H; Haider W; Geyer A; Mutz N; Pauser G
    Klin Anasthesiol Intensivther; 1979; 20():43-55. PubMed ID: 583433
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury.
    Häfner D; Germann PG; Hauschke D; Kilian U
    Pulm Pharmacol Ther; 1999; 12(3):193-201. PubMed ID: 10419839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H1N1: viral pneumonia as a cause of acute respiratory distress syndrome.
    Ramsey C; Kumar A
    Curr Opin Crit Care; 2011 Feb; 17(1):64-71. PubMed ID: 21157318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant.
    Vos GD; Rijtema MN; Blanco CE
    Pediatr Pulmonol; 1996 Dec; 22(6):412-5. PubMed ID: 9016476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection of laboratory animals with parainfluenza-3 virus.
    Singh VP; Pathak RC
    Indian J Exp Biol; 1979 Aug; 17(8):811-3. PubMed ID: 232483
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental models of acute respiratory distress syndrome: clinical relevance and response to surfactant therapy.
    Kobayashi T; Tashiro K; Cui X; Konzaki T; Xu Y; Kabata C; Yamamoto K
    Biol Neonate; 2001 May; 80 Suppl 1():26-8. PubMed ID: 11359042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of pulmonary gas exchange after surfactant replacement in rats with Pneumocystis carinii pneumonia.
    Eijking EP; van Daal GJ; Tenbrinck R; Sluiters JF; Hannappel E; Erdmann W; Lachmann B
    Adv Exp Med Biol; 1992; 316():293-8. PubMed ID: 1288089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.